DNA X, Inc. Common Stock (NASDAQ: SONM) last traded at $3.10, down 12.80% on the session. The quote above updates while this page is open; the figures below are drawn from DNA X, Inc. Common Stock’s own filings and are restated only when a new one is published.
DNA X, Inc. Common Stock trades on NASDAQ under the ticker SONM. Its market capitalisation is $4.61 million.
Valuation measures for DNA X, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.61M |
|---|---|
| Enterprise value | $9.46M |
| Price / sales | 0.08 |
| Beta | 0.40 |
Trailing-twelve-month figures tagged in DNA X, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $59.11M |
|---|
| Net income (TTM) | -$8.55M |
|---|
| Gross margin | 18.33% |
|---|
| Operating margin | -13.47% |
|---|
| Cash | $900.0K |
|---|
Range and volume for SONM over the past 52 weeks.
| 52-week high | $16.97 |
|---|---|
| 52-week low | $2.52 |
| Volume | 14.2K |
| Average volume | 17.0K |
| Previous close | $3.56 |
Invest a chosen dollar amount in DNA X, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SONM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.